Biofrontera Ag ADR (BFRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BFRA | ANTX | ANEB | ||
| Company | Biofrontera Ag ADR | An2 Therapeutics Inc | Anebulo Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.10 | 2.56 | 3.13 | ||
| High | 3.10 | 2.67 | 3.13 | ||
| Low | 2.60 | 2.50 | 2.91 | ||
| Last | 2.67 | 2.56 | 2.95 | ||
| Change | -0.28 | +0.02 | -0.17 | ||
| % Change | -9.49% | +0.79% | -5.45% | ||
| Volume | 4,900 | 168,300 | 3,600 | ||
| 20-Day Average Volume | 28,690 | 230,895 | 5,020 | ||
| Previous Close | 2.95 | 2.54 | 3.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.98 | 2.56 | 2.85 | ||
| 20-Day Raw Stochastic | 36.45% | 36.55% | 50.00% | ||
| 20-Day Relative Strength | 43.80% | 31.56% | 55.04% | ||
| Weighted Alpha | -61.60 | +17.62 | +11.81 | ||
| Today's Opinion | 96% Sell | 96% Sell | 88% Buy | ||
| Previous Opinion | 96% Sell | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.87% since 02/25/22 | +10.34% since 04/26/24 | +9.11% since 04/26/24 | ||
| Low | 2.58 on 03/02/22 | 2.34 on 04/29/24 | 2.67 on 04/29/24 | ||
| High | 3.30 on 02/28/22 | 2.67 on 05/03/24 | 3.20 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | -6.43% since 02/04/22 | -24.04% since 04/03/24 | +2.61% since 04/03/24 | ||
| Low | 2.09 on 02/14/22 | 2.20 on 04/26/24 | 2.60 on 04/10/24 | ||
| High | 3.68 on 02/09/22 | 3.54 on 04/04/24 | 3.30 on 04/18/24 | ||
| 3-Month | |||||
| %Chg | -21.47% since 12/03/21 | -87.45% since 02/02/24 | +15.23% since 02/02/24 | ||
| Low | 2.09 on 02/14/22 | 2.20 on 04/26/24 | 2.40 on 03/22/24 | ||
| High | 3.99 on 12/21/21 | 21.40 on 02/06/24 | 3.30 on 04/18/24 | ||
| 6-Month | |||||
| %Chg | -54.82% since 09/03/21 | -83.00% since 11/03/23 | +44.61% since 11/03/23 | ||
| Low | 2.09 on 02/14/22 | 2.20 on 04/26/24 | 1.87 on 12/14/23 | ||
| High | 6.89 on 10/22/21 | 22.22 on 01/10/24 | 3.30 on 04/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 75,719 | 76,362 | 75,617 | ||
| Shares Outstanding, K | 28,359 | 29,829 | 25,633 | ||
| Annual Sales | 34,660,000 | 0 | 0 | ||
| Annual Net Income | -14,880,000 | -64,730,000 | -11,730,000 | ||
| Last Quarter Sales | 6,340,000 | 0 | 0 | ||
| Last Quarter Net Income | -6,840,000 | -16,900,000 | -2,720,000 | ||
| 60-Month Beta | 1.02 | -0.05 | -0.98 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.57 on 03/28/24 | -0.11 on 02/13/24 | ||
| Latest Earnings Date | 04/11/22 | 05/09/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||